skip navigation
|
|
|
|
| Legal > New High Cost Drugs Introduced in New Hampshire |
 |
| Prescription drug manufacturers are required by New Hampshire law to provide certain notice to the Insurance Department if they are introducing a new prescription drug to market at a wholesale acquisition cost that exceeds the threshold set for a specialty drug under the Medicare Part D program (House Bill 703, NH RSA 318:67-68, III). |
| |
|
This dashboard shows the details of the drugs brought to market since January 1, 2020.
If you have any questions, comments or feedback on the dashboard, please email doi.healthcareanalytics@ins.nh.gov.
|
| |
|
